GlassScriptPhysician profile
Asma Abdulrazzak
NPI 1629141619
$1,119.83
in general payments reported to CMS, 2019-2025
12 companies · $44.05 in 2025
The $44.05 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $241 · 2021: $441 · 2022: $38.72 · 2023: $167 · 2024: $75.00 · 2025: $44.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.86 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $423.48 | 2020-2022 | |
| Align Technology, INC. | $289.67 | 2020-2024 | Invisalign |
| Ivoclar Vivadent, INC. | $124.89 | 2023 | |
| Coltene Whaledent INC. | $75.00 | 2019 | |
| Dentsply Sirona INC | $55.64 | 2022-2023 | Suresmile |
| Planmeca USA, INC. | $35.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $24.84 | 2019 | |
| Solventum Corporation | $22.99 | 2025 | Clarity Aligners |
| Biohorizons Implant Systems INC. | $21.06 | 2025 | Biohorizons Dental Prosthetics |
| Ultradent Products INC | $17.52 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.10 | 2020 | |
| Biolase, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asma Abdulrazzak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.